Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,859 | 102,265 | 102,909 | 101,247 | 100,426 |
| Receivables | 17,643 | 17,626 | 15,808 | 17,497 | 15,889 |
| Inventories | 34,670 | 34,955 | 32,775 | 35,563 | 39,213 |
| TOTAL | $157,256 | $157,095 | $154,269 | $157,411 | $158,003 |
| Non-Current Assets | |||||
| PPE Net | 39,020 | 32,495 | 29,781 | 26,994 | 25,576 |
| Intangibles | 63,915 | 64,614 | 65,313 | 66,012 | 66,711 |
| Other Non-Current Assets | 41,858 | 41,596 | 42,345 | 42,852 | 41,133 |
| TOTAL | $144,793 | $138,705 | $137,439 | $135,858 | $133,420 |
| Total Assets | $302,049 | $295,800 | $291,708 | $293,269 | $291,423 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 16 |
| Accounts payable and accrued liabilities | 14,559 | 15,717 | 15,634 | 19,195 | 22,620 |
| Accrued Expenses | 17,932 | 16,331 | 15,165 | 16,265 | 14,201 |
| TOTAL | $32,491 | $32,048 | $30,799 | $35,460 | $36,837 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 43,950 | 43,235 | 42,521 | 41,818 |
| Other Non-Current Liabilities | 18,612 | 12,126 | 9,474 | 6,994 | 5,639 |
| TOTAL | $74,280 | $111,842 | $109,723 | $106,197 | $103,452 |
| Total Liabilities | $106,771 | $143,890 | $140,522 | $141,657 | $140,289 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,945 | 56,189 | 55,736 | 55,201 | 54,774 |
| Common Shares | 59 | 56 | 56 | 55 | 55 |
| Retained earnings | -340,035 | -334,972 | -329,828 | -325,264 | -319,986 |
| Other shareholders' equity | 257 | 418 | 416 | 630 | 879 |
| TOTAL | $195,278 | $151,910 | $151,186 | $151,612 | $151,134 |
| Total Liabilities And Equity | $302,049 | $295,800 | $291,708 | $293,269 | $291,423 |